Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-12-16Clinical Trial Update: Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
This completed clinical trial evaluated the value of FLT-PET imaging before and during radiotherapy in head and neck cancer.
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Treatment Selection According to Skin Reaction to Cetuximab [Phase 2]
A Phase 2 clinical trial explores whether skin reaction to cetuximab can guide treatment selection in patients with head and neck cancer.
-
CLINICAL_TRIALS research · 2011-12-12Clinical Trial Update: Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
Clinical trial update for a phase 1/2 study of everolimus plus docetaxel in recurrent, locally advanced, or metastatic head and neck cancer;…
-
CLINICAL_TRIALS research · 2011-10-06Clinical Trial Update: RGD-K5 in Head and Neck Cancer Patients
This document reports a clinical trial update for the investigational agent RGD-K5 in patients with head and neck cancer; the current trial …
-
CLINICAL_TRIALS research · 2011-08-24Clinical Trial Update: Study of Chemo-Immunotherapy in Head and Neck Cancer Patients [Phase 1]
A Phase 1 clinical trial update investigating chemo-immunotherapy for head and neck cancer, with current status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer. [Phase 3]
Phase 3 clinical trial update comparing 3D conformal radiotherapy (3DCRT) with image-guided radiotherapy (IGRT) and analyzing early response…
-
CLINICAL_TRIALS research · 2011-06-08Clinical Trial Update: Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer
A completed clinical trial explored whether contact allergies to dental metal may be a risk factor for oral cancer, including head and neck …
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients [Phase 3]
A Phase 3 clinical trial comparing oral pilocarpine (Salagen) to a submandibular salivary gland transfer protocol for preventing radiation-i…
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia [Phase 3]
Phase 3 clinical trial comparing parotid-sparing intensity-modulated radiation therapy with conventional radiation therapy for oropharyngeal…
-
CLINICAL_TRIALS research · 2010-12-24Clinical Trial Update: Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery [Phase 1, Phase 2]
Updates on a Phase 1/2 clinical trial evaluating celecoxib for patients with head and neck cancer that can be removed by surgery.
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of the radiotracer [18F]-ML-10 to detect tumor response to chemotherapy and radiot…
-
CLINICAL_TRIALS research · 2010-10-07Clinical Trial Update: Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors [Phase 3]
A Phase 3 trial comparing intensity-modulated radiation therapy (IMRT) with 3-D conformal radiation therapy to reduce hearing loss after sur…
-
CLINICAL_TRIALS research · 2010-07-28Clinical Trial Update: Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
This document provides an update on a clinical trial investigating biomarkers from blood and tissue in head and neck cancer, including laryn…
-
CLINICAL_TRIALS research · 2009-11-04Clinical Trial Update: Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles [Phase 1]
Phase 1 clinical trial investigating antibacterial properties of silicon-incorporated quaternary ammonium polyethylenimine nanoparticles, sp…
-
CLINICAL_TRIALS research · 2009-09-02Clinical Trial Update: Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment [Phase 3]
Phase 3 double-blind, placebo-controlled study assessing whether escitalopram reduces emotional distress in head and neck cancer patients du…
-
CLINICAL_TRIALS research · 2009-02-06Clinical Trial Update: Functional Imaging in HNC Undergoing Chemoradiation
This entry notes a clinical trial exploring functional imaging in head and neck cancer patients undergoing chemoradiation, sponsored by Roya…
-
CLINICAL_TRIALS research · 2008-10-31Clinical Trial Update: Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
This clinical trial update describes validation of FDG-PET segmentation tools for delineating tumors by correlating CT- and FDG-PET volume m…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating Paclitaxel for recurrent or refractory head and neck cancer; current status is unknown.
-
CLINICAL_TRIALS research · 2008-01-29Clinical Trial Update: COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma [Phase 3]
This entry reports on a Phase 3 trial evaluating a COX-2 inhibitor with concurrent chemoradiation for locally advanced head and neck cancer,…
-
CLINICAL_TRIALS research · 2006-05-12Clinical Trial Update: Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
This clinical trial update discusses using plasma circulating DNA as a biomarker to monitor treatment response in head and neck cancer and e…